LEP and breast cancer: Some adipokines expression levels in serum, like resistin, leptin, adiponectin, and visfatin, can serve as risk factors for clinicopathological features of post-menopausal breast cancer, including tumor-node-metastasis (TNM) stage, tumor size, LN metastasis, and histological grade [133].